Skip to content

Effect of aggressive hydration therapy in prevention of complication of endoscopic theraputic intervention on billiary duct.

Evaluation of short term protective effect of aggressive hydration therapy with lactated ringer’s solution on pancreatitis after endoscopic retrograde cholangiopancreatography

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201410161213N3
Enrollment
150
Registered
2014-10-19
Start date
2014-11-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatitis. Acute pancreatitis

Interventions

Intervention 1: In case group lactated ringer serum administer with dose of 20 cc per kilogram of body mass and continue with 3 cc per kilogram of body mass until 8 hours. Intervention 2: In control
Treatment - Drugs
In case group lactated ringer serum administer with dose of 20 cc per kilogram of body mass and continue with 3 cc per kilogram of body mass until 8 hours.
In control group lactated ringer serum administer with dose of 1.5 cc per kilogram of body mass until 8 hours.

Sponsors

Vice-chancellor for research -Tabriz University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (Inclusion criteria:Indication of endoscopic retrograde cholangiopancreaticography; consent of enrollment in study and Exclusion criteria:Acute cholangitis; sepsis; pregnancy; age above 70 years; chronic pancreatitis; acute pancreatitis due to billiary stone; risk of fluid overload; peripheral edema; pulmonary edema; electrolyte disturbance for example Na over 150 or below 130; history of endoscopic retrograde cholangiopancreaticography performation with sphinctrotomy.)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Post endoscopicretrograde cholangiopancreaticography pancreatitis. Timepoint: 2,8 and 24 hours after intervation. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Hyper amylasemia. Timepoint: 2, 8 and 24 after intervation. Method of measurement: U/L.;Pain. Timepoint: 2, 8 and 24 after intervation. Method of measurement: Visual analouge pain scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Reza Shaygan nezhad

Tabriz University of Medical Sciences

ali.shayegan@yahoo.com+98 41 3334 7554

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026